Captopril and Tyvaso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Captopril (captopril) and Tyvaso (treprostinil sodium). Common drug interactions include death among females and blood urine present among males.

The phase IV clinical study analyzes what interactions people have when they take Captopril and Tyvaso. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.

What is Tyvaso?

Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.



On Jul, 27, 2026

11 people who take Captopril and Tyvaso together, and have interactions are studied.

Captopril and Tyvaso drug interactions.

What are the common drug interactions of Captopril and Tyvaso, by gender? *:

female:

  1. Death
  2. Cardiac failure
  3. Headache (pain in head)
  4. Pain in jaw

male:

  1. Blood urine present
  2. Diarrhoea
  3. Blood phosphorus decreased
  4. Cellulitis (infection under the skin)
  5. Ocular vascular disorder (disease of eye blood circulation)
  6. Pleuritic pain
  7. Respiratory tract infection
  8. Septic shock (shock due to blood infection)
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Hypoxia (low oxygen in tissues)

What are the common drug interactions of Captopril and Tyvaso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Fatigue (feeling of tiredness)
  2. Periorbital cellulitis (inflammation and infection of the eyelid and the skin surrounding the eye)
  3. Platelet count decreased
  4. Weight decreased
  5. White blood cell count decreased
  6. Acute respiratory failure
  7. Asthenia (weakness)
  8. Blood phosphorus decreased
  9. Cellulitis (infection under the skin)
  10. Ocular vascular disorder (disease of eye blood circulation)

40-49:

  1. Death
  2. Cardiac failure
  3. Headache (pain in head)
  4. Pain in jaw

50-59:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Hypoxia (low oxygen in tissues)
  3. Respiratory distress (difficulty in breathing)

60+:

n/a

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 90.91%
  2. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 6 people, 54.55%
  3. Depression: 3 people, 27.27%
  4. Stress And Anxiety: 3 people, 27.27%
  5. Skin Ulcer: 3 people, 27.27%
  6. Pain: 3 people, 27.27%
  7. Scrotal Ulcer: 3 people, 27.27%
  8. Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 27.27%
  9. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 27.27%
  10. Immunodeficiency Disorders: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Captopril and Tyvaso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Captopril and Tyvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tyvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Captopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tyvaso and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on captopril and treprostinil sodium (the active ingredients of Captopril and Tyvaso, respectively), and Captopril and Tyvaso (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: